in ,

2022 Radiological Society of North America (RSNA) Annual Meeting: Bayer to showcase product offerings and announces broadened AI offering in Radiology

Advertisements

PITTSBURGH–()–As international leaders in imaging gather for the 2022 Radiological Society of North America (RSNA) Annual Meeting, Bayer Radiology, a leader in diagnostic imaging, will showcase its portfolio of products and solutions aimed at deal with today’s most pressing problems facing the field of Radiology. In addition, Bayer will present new scientific data on an experimental contrast agent. RSNA 2022 will take place November 27-December 1 in Chicago.

Bayer’s areas of focus at RSNA represent the company’s commitment to help address staff shortages with solutions that focus on patient productivity and workflow efficiency to drive automation and standardization, investing in science for the benefit of patients and their doctors, and leveraging the vast potential of data and artificial intelligence.

Next-generation CT technology and workflow solutions highlight integrated offerings that handle complexity and deliver accurate diagnostic information more efficiently.

Bayer’s introduction of the Injector Management* software enables consistency and standardization by offering the ability to share common protocols via connected injectors. *not yet commercially available.

Bayer to showcase its next-generation CT technology, MEDRAD Centargo CT Injection System (Centargo) at RSNA (Centargo is 510(k) pending and not available for sale in the US. The latest addition to Bayer’s CT portfolio is designed to drive workflow efficiency with design features that work in conjunction with Bayer’s product portfolio to bring innovative technology to the imaging suite and introduce new technologies to patient setup areas.

Andexpand the AI ​​offerings on CalanticTM extension Digital solutions

Bayer Also Announces Collaboration Agreements With App Developers Quantib, ClariPi, and EXINI Diagnostics to Strategically Expand Offerings on its Calantic Medical Imaging PlatformTM extension Digital solutions. The platform, which was recently launched, provides access to applications, including those enabled by artificial intelligence, for medical imaging. With these new collaboration agreements, Bayer is expanding the options already available for thoracic and neurological diseases on the platform to include tools that aim to facilitate breast and prostate imaging.

Introducing the Calantic App Accelerator ProgramTM extension SPARK

Also, Bayer recently launched CalanticTM extension SPARK, a new accelerator program for medical imaging app developers to further drive innovation in radiology AI. The program will initially focus on North America and Europe and is expected to be expanded to other regions, including Asia-Pacific. Bayer offers a focused program designed to accelerate market readiness for early stage projects and offerings, providing advice ranging from medical, regulatory, reimbursement and market access expertise. Leveraging the burgeoning artificial intelligence start-up ecosystem in medical imaging, Calantic SPARK offers program participants a potential path to commercialization and distribution through Calantic Digital Solutions. Details on the Calantic SPARK will be presented at the Bayer booth and the AI ​​Showcase Theater at the RSNA.

Corporate symposiums

The role of a highly relaxant contrast agent in central nervous system imaging and MRA

Monday, November 28, 9:30 (CT)

Room: S102AB

From AI Inception to Validation; The role of AI orchestration platforms

At the Showcase Theater Presentation

Monday, November 28, 1:00 pm (CT)

Room: S102AB

Sparks of collaboration, How Bayer is engaging with the startup ecosystem.

Monday, November 28, 11:00, (CT)

Hall: Theater AI

Techniques and considerations in liver imaging.

Tuesday November 29, 10:30, (CT)

Virtual Product Theater

Drive AI innovation to rate reimbursable apps

Wednesday, November 30, 3:00 PM (CT)

Theater of innovation

Scientific presentation on a new experimental molecular entity

Bayer will present the results of the first clinical trial data on an experimental contrast agent. Gadoquatrane is a gadolinium-based contrast agent in phase II development. The study examined the pharmacokinetics, including excretion routes, safety and tolerability of gadoquatrane in healthy volunteers.

  • Session number: R5A-SPNR; December 1; 12:15 – 12:45, (CT)

About Bayer

Bayer is a global company with core competencies in the health care life sciences and nutrition industries. Its products and services are designed to help people and the planet thrive by supporting efforts to address the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its activities. At the same time, the Group aims to increase its profitability and to create value through innovation and growth. The Bayer brand stands for trust, reliability and quality worldwide. In fiscal 2021, the Group employed around 100,000 people and had revenues of €44.1 billion. Research and development expenses before special items amount to 5.3 billion euros. For more information, go to www.bayer.com.

Find more information about https://pharma.bayer.com/

Follow us on Facebook: http://www.facebook.com/bayer

Follow us on Twitter: @BayerPharma

Forward-Looking Statements

This press release may contain forward-looking statements based on current assumptions and forecasts made by Bayer’s management. Various known and unknown risks, uncertainties and other factors could cause actual future results, financial condition, company development or performance to differ materially from the estimates provided herein. These factors include those discussed in Bayer’s public relations, available on Bayer’s website at www.bayer.com. The company assumes no responsibility for the currency or conformity of these forward-looking statements them to future events or developments.

Advertisements
Advertisements

What do you think?

Written by Natalia Chi

Chicago Popular; Chicago breaking news, weather and live video. Covering local politics, health, traffic and sports for Chicago, the suburbs and northwest Indiana.

Leave a Reply

Man killed, 1 wounded in East Garfield Park shooting

Thanksgiving meal distribution canceled after fire in suburban Chicago food pantry